Latest News about JNJ
Recent news which mentions JNJ
From Motley Fool
What 13 Analyst Ratings Have To Say About Johnson & Johnson
April 02, 2025
Tickers
JNJ
From Benzinga
From Benzinga
Newsmax, Waton Financial, Johnson & Johnson, Hims & Hers Health, Tesla: Why These 5 Stocks Are On Investors' Radars Today
April 01, 2025
From Benzinga
Johnson & Johnson Stock Is Tumbling Tuesday: What Going On?
April 01, 2025
From Benzinga
From Benzinga
From Benzinga
US Judge Rejects Another Johnson & Johnson Attempt To Use Bankruptcy For Talc Cancer Claims
April 01, 2025
From Benzinga
2 Value Stocks I'm Buying Right Now
April 01, 2025
From Motley Fool
Value Stocks Gain Ground As Inflation, Recession Fears Grow: 4 ETFs To Capitalize On The Trend
March 31, 2025
From Benzinga
Is Hims & Hers Stock Too Cheap to Pass Up?
March 29, 2025
From Motley Fool
3 Relatively Safe Stocks to Buy Right Now
March 29, 2025
From Motley Fool
From Motley Fool
2 Recession-Proof Dividend Stocks to Buy and Hold
March 27, 2025
From Motley Fool
From Benzinga
From Benzinga
FDA Approves Johnson & Johnson's Tremfya For Crohn's Disease
March 21, 2025
From Benzinga
From Benzinga
Johnson & Johnson's Golden Cross: Technical Momentum Meets Groundbreaking Lung Cancer Breakthrough
March 20, 2025
Tickers
JNJ
From Benzinga
From Motley Fool
Alpha Cognition Is 'Under-Followed' As Alzheimer Drug Targets $2 Billion Long Term Care Market: Analyst
March 18, 2025
From Benzinga
FDA Grants Fast Track Review To Johnson & Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva
March 18, 2025
From Benzinga
Cancer-Focused Nanobiotix Adjusts $2.7 Billion Johnson & Johnson Agreement To Strengthen Finances And Relieve Funding Burden
March 18, 2025
From Benzinga
From Motley Fool
From Motley Fool
Coinbase, Apple And Robinhood Are Among Top Large-Cap Losers Last Week (Mar 10-Mar 14): Are The Others In Your Portfolio?
March 16, 2025
From Benzinga
Allegations of Inflated Prescription Drug Costs Spark Employee Lawsuit Against JPMorgan
March 15, 2025
From Benzinga
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.